BAILEY PENDERGRAFT: Open Payments
NPI 1376251470 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,443 in 114 payments from 20 companies in 2025. Trend: 2023 $2,371 · 2024 $2,153 · 2025 $2,443
Food & beverage: $2,443
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $388 |
| GENZYME CORPORATION | 13 | $308 |
| UCB, Inc. | 15 | $258 |
| ABBVIE INC. | 12 | $250 |
| Galderma Laboratories, L.P. | 8 | $237 |
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| Janssen Biotech, Inc. | 15 | $159 |
| SANOFI US SERVICES INC. | 1 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $79 |
| Lilly USA, LLC | 3 | $68 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, SKYRIZI, AYVAKIT, TREMFYA, COSENTYX, OTEZLA.
Industry payments across TX — which companies pay providers there.
